Partner with Renewal Weekly

Renewal Weekly started in 2019 when we realized patients researching regenerative treatments had nowhere to turn for trustworthy, unbiased information. The space was flooded with clinic marketing and overpromising headlines. We set out to change that.

Today, we operate a weekly newsletter that is read by patients, caregivers, physicians, and researchers across 40+ countries. Our content comes from direct experience in the regenerative medicine industry, combined with careful analysis of the latest research. To keep readers engaged we write about the latest health news and innovation based on peer-reviewed research. We don't hype miracle cures. We explain what works, what doesn't, and what's still unknown.

Stem cell therapy developments, exosome research, peptide protocols, longevity interventions, NAD+ and mitochondrial health, autoimmune approaches, orthopedic regeneration, and the regulatory landscape shaping patient access. We will also cover exciting health innovations that may positively or negatively impact the boomers.

How we're different

We have skin in the game. Our team has over a decade of experience working with people considering healthcare interventions. That shapes how we write—practical, honest, and focused on what actually matters to someone weighing a potentially significant financial decision. Our content is focused on providing exciting data from peer reviewed research that is translated for the average reader to understand.

Every subscriber on this list opted in through specialized regenerative health content. No giveaways, no purchased lists, no Facebook lead ads. They found us because they were actively researching treatment options—and they've stayed because we deliver value week after week.

Demographics

Age: 55-68 primary range
Income: $150k+ household
Education: College-educated professionals
Location: US, Canada, UK, Australia

What they are researching

Stem cell treatments for degenerative conditions, longetivity and healthspan optimization, alternatives to surgery or long-term medication, international treatment options, natural anti-inflammatory supplementation, autoimmune research, clinical trials.

Our readers aren't casually browsing health content. They're deep in their research journey, actively comparing options, and ready to take action. When your message appears in Renewal Weekly, it lands in a context of trust—not interruption.

‍
Our 24,000+ subscribers are educated professionals ages 45-75 actively seeking regenerative health solutions—many willing to invest $25K+ in treatments. They're comparing providers, evaluating protocols, and deciding where to invest in their health. A recommendation in Renewal Weekly carries weight because we've earned their trust over years—not because we bought their email address last month.

Clean, scannable, and designed for busy readers. Short paragraphs, clear headers, and visuals that actually help, no walls of text, no filler.

Every issue is crafted for how people actually read email: key takeaways up front, short paragraphs that work on mobile, and clear headers so readers can skip to what matters to them. We use charts and visuals when they clarify, not to fill space. No jargon, no fluff, no burying the point three paragraphs down. Readers get the information they need without wading through content that respects their time.

We explain complex science in plain language, but we don't talk down to an audience that's been researching their conditions for years. It's the balance between accessible and substantive, and it's why readers actually finish what we send.